THERAGENICS CORP (TGX) financial statements (2021 and earlier)
Company profile
| Business Address |
5203 BRISTOL INDUSTRIAL WAY BUFORD, GA 30518 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3825 - Instruments for Measuring and Testing of Electricity and Electrical Signals (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 6/30/2013 Q2 | 3/31/2013 Q1 | 12/31/2012 Q4 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 37 | 34 | |||
| Cash and cash equivalents | 17 | 16 | |||
| Short-term investments | 20 | 18 | |||
| Receivables | 10 | 10 | |||
| Inventory, net of allowances, customer advances and progress billings | 15 | 16 | ✕ | ||
| Inventory | 15 | 16 | |||
| Prepaid expense and other current assets | ✕ | 1 | |||
| Other undisclosed current assets | 2 | 1 | |||
| Total current assets: | 64 | 62 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 32 | 32 | |||
| Intangible assets, net (including goodwill) | 9 | 10 | ✕ | ||
| Intangible assets, net (excluding goodwill) | 9 | 10 | |||
| Other noncurrent assets | 0 | ✕ | |||
| Prepaid expense and other noncurrent assets | ✕ | 0 | |||
| Other undisclosed noncurrent assets | 1 | 1 | |||
| Total noncurrent assets: | 43 | 43 | |||
| TOTAL ASSETS: | 107 | 105 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4 | 4 | |||
| Accounts payable | 2 | 2 | |||
| Employee-related liabilities | 2 | 2 | |||
| Taxes payable | 0 | 0 | |||
| Other liabilities | 2 | 1 | |||
| Total current liabilities: | 6 | 5 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 22 | 22 | |||
| Long-term debt, excluding current maturities | 22 | 22 | |||
| Liabilities, other than long-term debt | 1 | 1 | |||
| Asset retirement obligations | 1 | 1 | |||
| Other liabilities | 0 | 0 | |||
| Total noncurrent liabilities: | 23 | 23 | |||
| Total liabilities: | 29 | 28 | |||
| Stockholders' equity | |||||
| Stockholders' equity attributable to parent | 78 | 77 | |||
| Common stock | 0 | 0 | |||
| Treasury stock, value | (10) | (10) | |||
| Additional paid in capital | 76 | 76 | |||
| Accumulated other comprehensive income (loss) | (0) | 0 | |||
| Retained earnings | 11 | 11 | |||
| Total stockholders' equity: | 78 | 77 | |||
| TOTAL LIABILITIES AND EQUITY: | 107 | 105 | |||
Income statement (P&L) ($ in millions)
| 6/30/2013 Q2 | 3/31/2013 Q1 | 12/31/2012 Q4 | ||
|---|---|---|---|---|
| Revenues (Revenue, Net) | 20 | 20 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (13) | (13) | ||
| Gross profit: | 8 | 7 | ||
| Operating expenses | (8) | (7) | ||
| Operating income: | 0 | 0 | ||
| Nonoperating expense | (0) | (0) | ||
| Investment income, nonoperating | 0 | 0 | ||
| Interest and debt expense | (0) | (0) | ||
| Loss from continuing operations before equity method investments, income taxes: | (0) | (0) | ||
| Other undisclosed income from continuing operations before income taxes | 0 | 0 | ||
| Income (loss) from continuing operations before income taxes: | 0 | (0) | ||
| Income tax expense (benefit) | (0) | 0 | ||
| Net loss available to common stockholders, diluted: | (0) | (0) | ||
Comprehensive Income ($ in millions)
| 6/30/2013 Q2 | 3/31/2013 Q1 | 12/31/2012 Q4 | ||
|---|---|---|---|---|
| Net loss: | (0) | (0) | ||
| Comprehensive loss: | (0) | (0) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (0) | |||
| Comprehensive loss, net of tax, attributable to parent: | (0) | (0) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.